Skip to main navigation Skip to search Skip to main content

Antimycobacterial metabolites from Plectranthus: Royleanone derivatives against Mycobacterium tuberculosis strains

  • Patrícia Rijo
  • , M. Fátima Simões
  • , A. Paula Francisco
  • , Rosario Rojas
  • , Robert H. Gilman
  • , Abraham J. Vaisberg
  • , Benjamín Rodríguez
  • , Cristina Moiteiro
  • University of Lisbon
  • Universidad Peruana Cayetano Heredia
  • Instituto de Química Orgánica-CSIC
  • DTIQ

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

The antimycobacterial activities of eight diterpenes, 1-8, isolated previously from Plectranthus and eleven esters, 9-19, of 7α-acetoxy- 6β,12-dihydroxyabieta-8,12-diene-11,14-dione (5) were evaluated against the MTB strains H37Rv and MDR. Only diterpenoids with a quinone framework revealed anti-MTB activity. Abietane 5 and its 6,12-dibenzoyl, 12-methoxybenzoyl, 12-chlorobenzoyl, and 12-nitrobenzoyl esters, 9, 11, 12, and 13, respectively, showed potent activities against the MDR strain with MIC values between 3.12 and 0.39 μg/ml. Cytotoxic activities towards 3T3 and Vero cells were also evaluated. Compound 11, with the best selectivity index, may be a suitable lead for further chemical modifications. The complete structural elucidation of the new esters, 9-14, 16, 18, and 19, as well as the NMR data of known derivatives 15 and 17 are reported.

Original languageEnglish
Pages (from-to)922-932
Number of pages11
JournalChemistry and Biodiversity
Volume7
Issue number4
DOIs
StatePublished - Apr 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Antimycobacterial metabolites from Plectranthus: Royleanone derivatives against Mycobacterium tuberculosis strains'. Together they form a unique fingerprint.

Cite this